Verfügbarkeit: Kistner's gynecology and women's health

Kistner's gynecology and women's health:

Gespeichert in:

Bibliographische Detailangaben
Format:	Buch
Sprache:	English
Veröffentlicht:	St. Louis [u.a.] Mosby 1999
Ausgabe:	7. ed.
Schlagworte:	Frau Genital Diseases, Female Genital Neoplasms, Female Gynecology Women > Health and hygiene Women's Health Gynäkologie Lehrbuch
Online-Zugang:	Inhaltsverzeichnis
Beschreibung:	XXVI, 660 S. Ill., graph. Darst.
ISBN:	0323002013

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV012855857
003	DE-604
005	19991228
007	t
008	991112s1999 ad\|\| \|\|\|\| 00\|\|\| eng d
020			\|a 0323002013 \|9 0-323-00201-3
035			\|a (OCoLC)40964902
035			\|a (DE-599)BVBBV012855857
040			\|a DE-604 \|b ger \|e rakddb
041	0		\|a eng
049			\|a DE-355
050		0	\|a RG101
082	0		\|a 618.1 \|2 21
084			\|a YM 1300 \|0 (DE-625)153814: \|2 rvk
245	1	0	\|a Kistner's gynecology and women's health \|c Kenneth J. Ryan ...
246	1	3	\|a Gynecology and woman's health
250			\|a 7. ed.
264		1	\|a St. Louis [u.a.] \|b Mosby \|c 1999
300			\|a XXVI, 660 S. \|b Ill., graph. Darst.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
650		4	\|a Frau
650		4	\|a Genital Diseases, Female
650		4	\|a Genital Neoplasms, Female
650		4	\|a Gynecology
650		4	\|a Women \|x Health and hygiene
650		4	\|a Women's Health
650	0	7	\|a Gynäkologie \|0 (DE-588)4018225-3 \|2 gnd \|9 rswk-swf
655		7	\|0 (DE-588)4123623-3 \|a Lehrbuch \|2 gnd-content
689	0	0	\|a Gynäkologie \|0 (DE-588)4018225-3 \|D s
689	0		\|5 DE-604
700	1		\|a Ryan, Kenneth J. \|e Sonstige \|4 oth
856	4	2	\|m HBZ Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008747421&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-008747421

Datensatz im Suchindex

_version_	1804127535302180864
adam_text	G Part I GYNECOLOGY OVERVIEW 1 Evidence Based Gynecology, 3 David W. Bates 2 Medical Ethics and Risk Management, 12 Kenneth J. Ryan Part II THE REPRODUCTIVE SYSTEM AND DISEASE 3 The Menstrual Cycle, 23 Robert L. Barbieri Kenneth J. Ryan 4 The Vulva, 58 Michael G. Muto 5 The Vagina, 81 Joan M. Bengtson 6 The Cervix, 93 Ellen E. Sheets 7 The Uterine Corpus, 121 Sarah Feldman Elizabeth A. Stewart ontents 8 The Fallopian Tube and Ectopic Pregnancy, 143 Helen H. Kim Janis H. Fox 9 The Ovary, 166 Laurel W. Rice 10 The Breast, 191 Barbara L. Smith 11 Gestational Trophoblastic Disease, 218 Ross S. Berkowitz Donald P. Goldstein Part III THE REPRODUCTIVE LIFE CYCLE 12 Pediatric and Adolescent Gynecology, 233 Marc R. Laufer Donald P. Goldstein 13 Conception Control, 285 Rapin Osathanondh 14 The Infertile Couple, 325 Mitchell S. Rein Robert L. Barbieri xiii xiv Contents 15 Polycystic Ovary Syndrome and Hyperandrogenism, 373 Ann E. Taylor Andrea E. Dunaif 16 Recurrent Pregnancy Loss, 396 Joseph A. Hill 17 Medical Genetics, 423 Louise Wilkins Haug 18 Gynecologic Infections, 455 Ruth E. Tuomala Katherine T. Chen 19 Endometriosis, 492 Mark D. Hornstein Robert L. Barbieri 20 Psychological Aspects of Women s Reproductive Health, 519 Susan Caruso Klock 21 Menopause, 540 Brian W. Walsh Elizabeth S. Ginsburg 22 Urogynecology and Pelvic Floor Dysfunction, 570 Marie Andree Harvey Eboo Versi 23 Geriatrie Gynecology and Aging, 610 Karen L. Miller Eboo Versi Neil M. Resnick Detaile* PartI GYNECOLOGY OVERVIEW, 1 1 Evidence Based Gynecology, 3 The Old Paradigm, 3 The New Paradigm, 3 Keeping Up with the Literature, 4 Asking a Clinical Question, 4 Overview of Main Types of Studies, 5 Therapy and Prevention, 5 Therapy, 6 Diagnosis, 7 Harm, 8 Prognosis, 8 Overviews, 9 Practice Guidelines, 9 Decision Analyses, 10 Economic Analyses, 10 Conclusions, 10 2 Medical Ethics and Risk Management, 12 Moral Theories and Principles, 12 Theories, 12 Principles, 13 Ethics and the Practice of Gynecology, 13 Making Moral Judgements and Resolving Conflict, 13 Ethics, Science, and Competency in Medicine, 13 Doctor Patient Relationship, 14 Ethical and Political Issues in Reproductive Care, Assisted Reproductive Technologies, 14 Abortion, 15 Pain, Terminal Care, Assisted Suicide, Euthanasia, 16 Hypothetical Case Studies, 17 Risk Management, 18 Informed Consent, 18 Conclusion, 19 i Contents Part II THE REPRODUCTIVE SYSTEM AND DISEASE, 21 3 The Menstrual Cyde, 23 CycleLength, 23 Menstrual Flow, 25 Integration of the Menstrual Cycle, 25 The Hypothalamus, 25 Abnormalities in GnRH Pulse Frequency Are Associated with Menstrual Dysfunction, 27 Pituitary Gland: Major Link Between Brain and Ovary, 27 Ovarian Development, 27 Follicular Development, 28 Follicular Microenvironment, 28 Selection and Dominance, 28 Ovulation, 28 Luteal Phase of the Cycle, 29 Ovarian Compartments, 29 Two Cell Theory, 30 Ovarian Regulatory Proteins, 31 Steroid Structure, 31 Biochemistry of Steroid Biosynthesis, 32 Steroid Pathways in the Ovarian Follicle and Corpus Luteum, 34 Interconversion of Androgens and Estrogens, 34 Endometrium, 34 Estrogen and Progesterone Effects on the Endometrium, 34 l Dating the Endometrium, 34 Clinical Pearls: Integration of the Menstrual Cycle, 43 Amenorrhea, 44 Primary Amenorrhea, 44 Secondary Amenorrhea, 44 Prolactinomas, 44 Empty Sella Syndrome, 47 Sheehan Syndrome, 47 Ovarian Causes of Secondary Amenorrhea, 47 Uterine Causes, 48 Laboratory Evaluation of Secondary Amenorrhea, 48 xvi Detailed Contents Abnormal and Excessive Uterine Bleeding, 48 Diagnostic Evaluation, 49 Hormonal Abnormalities that Cause Abnormal Uterine Bleeding, 50 Abnormal Uterine Bleeding Caused by Infection, 51 Abnormal Uterine Bleeding Caused by Coagulopathies, 52 Treatment of Life Threatening Uterine Bleeding, 52 Dysmenorrhea, 52 Premenstrual Syndrome, 54 4 TheVulva, 58 General Considerations, 58 Anatomy and Histology, 58 Mons and Labia, 58 Clitoris, 59 Vestibüle and Vulvar Glands, 60 Vestibular Bulbs, 60 Hymen, 60 Urethra, 61 Injuries, 61 Accidents, 61 Coital Injuries, 61 Infections and Sexual Diseases, 62 Condyloma Acuminata, 62 Treatment, 62 Fungal Infections, 63 Candida, 63 Tinea, 64 Intertrigo, 64 Parasites, 64 Scabies, 64 Pediculosis Pubis, 64 Other Infections, 64 Chancroid, 64 Lymphogranuloma Venereum, 65 Granuloma Inguinale, 65 Molluscum, 65 Folliculitis, 65 Necrotizing Fasciitis, 66 Hidradenitis Suppurativa, 66 Fox Fordyce Disease, 66 Systemic Diseases, 66 Acquired Immunodeficiency Syndrome, 67 Blood Dyscrasias, 67 Circulatory Disturbances, 67 Diabetes, 67 Uremia, 67 Vitamin Deficiencies, 67 Autoimmune Diseases, 67 Crohn Disease (Regional Enteritis), 67 Behcet Syndrome, 67 Nonneoplastic Epithelial Disorders, 68 Psoriasis, 68 Diagnosis, 68 Treatment, 68 Seborrheic Dermatitis, 68 Diagnosis, 68 Treatment, 68 Liehen Planus, 68 Diagnosis, 68 Treatment, 69 Reactive Dermatitis, 69 Diagnosis, 69 Treatment, 69 Vulvar Dermatoses, 69 Liehen Sclerosus, 69 Squamous Hyperplasia, 70 Ulcers, 70 Vulvar Pruritus, Vulvodynia, and Vestibulitis, 71 Pruritus Syndrome, 71 Treatment, 71 Vulvar Vestibulitis, 71 Tumors and Benign Growths, 71 Vulvar Tumors, 71 Bartholin s Cyst and Abscess, 71 Hernia of the Canal of Nuck, 72 Endometriosis, 72 Lipoma, 72 Fibroma, 72 Hidradenoma, 72 Vulvar Intraepithelial Neoplasia, 73 Etiology, 73 Diagnosis, 73 Treatment, 74 Malignant Neoplasms, 74 Squamous Cell Carcinoma, 74 Epidemiology, 74 Mode of Spread, 75 Classification and Staging, 75 Histologie Grade, 75 Treatment, 76 Treatment Based on Stage, 76 Management of Advanced Vulvar Cancer, 76 Treatment of Microinvasive Carcinoma oftheVulva, 76 Paget Disease, 76 Melanoma, 77 Carcinoma of Bartholin s Gland, 78 Basal Cell Carcinoma, 78 Sarcomas, 78 Verrucous Carcinoma, 78 Acknowledgments, 78 5 The Vagina, 81 Anatomy and Physiology, 81 Atrophie Vaginitis, 83 Dyspareunia, 83 Malformations, 84 Vaginal Agenesis, 84 Failure of Lateral Fusion, 85 Failure of Canalization, 85 Disorders of Pelvic Support, 86 Benign Conditions of the Vagina, 86 Diethylstilbestrol Associated Vaginal Abnormalities, 86 Vaginal Intraepithelial Neoplasia, 87 Malignant Neoplasms, 88 Squamous Cell Carcinoma, 88 Other Malignancies, 90 6 The Cervix, 93 Embryology, 93 Anatomy, 94 Physiology, 95 Physiologie Alterations, 95 Changes in Endocervical Mucosa, 95 Histology, 95 Histologie Portio, 95 Transformation Zone, 96 Histology of the Endocervix, 97 Squamous Metaplasia and Epithelialization, 97 Benign Cervical Lesions, 98 Cervical Polyps, 98 Leiomyomas, 98 Keratinization, 100 Herpes Simplex Virus, 100 Cervical Neoplasia, 100 Epidemiology, 100 Human Papillomavirus, 101 Preinvasive Cervical Lesions, 101 Adenocarcinoma In Situ, 103 Diagnosis of Cervical Neoplasia, 104 New Papanicolaou Smear Technologies, 105 Evaluation of the Abnormal Papanicolaou Smear, 106 Colposcopy and Cervical Biopsy, 106 When to Evaluate the Abnormal Papanicolaou Smear, 106 Therapy for Preinvasive Cervical Disease, 107 Cryocauterization, 107 Laser Therapy, 108 Large Loop Excision of the Transformation Zone, 108 Cervical Conization, 108 Invasive Cancer, 109 Symptoms and Diagnosis, 109 Differential Diagnosis, 109 Pathology, 110 Mode of Spread of Cervical Cancer, 110 Clinical Staging of Cervical Cancer, 111 Treatment, 112 Radical Surgery, 112 Radiation Therapy, 112 Neoadjuvant Chemotherapy, 113 Appropriate Therapy Based on Clinical Staging, 114 Recurrent Cervical Carcinoma, 115 Detailed Contents xvii Carcinoma of the Cervix During Pregnancy, 116 Clear Cell Adenocarcinoma of the Cervix, 117 Carcinoma of the Cervical Stump, 117 Incidental Invasive Cervical Carcinoma Found at Conservative Hysterectomy, 117 Cervical Adenocarcinoma, 117 Small Cell and Neuroendocrine Small Cell Carcinoma, 118 Cancer Metastatic to the Uterine Cervix, 118 7 The Uterine Corpus, 121 Clinically Relevant Anatomy, 121 Endometrium, 122 Abnormal Uterine Bleeding, 123 Pathologie Conditions of the Uterus, 126 Leiomyomas, 126 Incidence and Etiology, 126 Symptoms, 126 Diagnosis, 127 Treatment, 127 Adenomyosis, 127 Incidence and Etiology, 127 Pathology, 128 Microscopic Appearance, 128 Symptoms, 128 Treatment, 129 Endometrial Polyps, 129 Uterine Anomalies, 129 Congenital Anomalies, 129 Acquired Anomalies, 130 Asherman Syndrome, 130 Endometrial Hyperplasia, 131 Etiology, 131 Malignant Potential, 131 Diagnosis, 131 Treatment, 131 Endometrial Cancer, 132 RiskFactors, 132 Diagnosis, 133 Pathology, 134 Pretreatment Evaluation, 134 Staging, 134 Postoperative Care, 135 Adjuvant Therapy, 135 Prognosis, 135 Recurrence, 135 Treatment of Recurrent Endometrial Cancer, 135 Other Uterine Malignancies, 136 Uterine Sarcomas, 136 Natural History, 136 Diagnostic Modalities, 136 Endometrial Biopsy, 136 Pelvic Ultrasonography, 136 Dilation and Curettage, 136 Sonohysterography, 137 Office Hysteroscopy, 137 xviii Detailed Contents Hysterosalpingography, 137 Magnetic Resonance Imaging, 137 Management Strategies, 137 Operative Hysteroscopy, 137 Endometrial Ablation, 137 Hysterectomy, 137 Types of Hysterectomy and How to Choose, 138 Vaginal Hysterectomy, 138 Laparoscopy Assisted Vaginal Hysterectomy, 138 Supracervical Hysterectomy, 138 Total Abdominal Hysterectomy, 138 Radical Hysterectomy, 138 Preoperative Evaluation, 138 8 The Fallopian Tube and Ectopic Pregnancy, 143 Anatomy, Histology, and Physiology, 143 Anatomy, 143 Histology, 144 Tubal Physiology, 145 Disorders of the Fallopian Tube, 145 Salpingitis, 145 Salpingitis Isthmica Nodosa, 146 Tubal Infertility, 146 Tubal and Paratubal Neoplasms, 147 Ectopic Pregnancy, 150 Definition and Clinical Significance, 150 Clinical Findings, 151 History, 151 Physical Examination, 151 Diagnostic Testing, 152 Human Chorionic Gonadotropin, 152 Transvaginal Ultrasonography, 152 Serum Progesterone, 153 Uterine Curettage, 153 Culdocentesis, 153 Management, 154 Surgical Management, 154 Nonsurgical Management, 157 Expectant Management, 160 Special Situations, 161 Conclusions, 162 9 TheOvary, 166 Epidemiology, 166 General, 166 Factors Denoting Increased Ovarian Cancer Risk, 166 Factors Associated with Decreased Ovarian Cancer Risk, 167 Ovarian Cancer Prevention, 168 Nonsurgical Prevention of Ovarian Cancer, 168 Surgical Prevention of Ovarian Cancer, 168 Classification, 168 Symptoms, 168 Physical Findings, 169 Differential Diagnosis of Adnexal Mass, 169 Nongynecologic, 169 Diverticular Disease, 169 Appendiceal Abscess, 169 Crohn Disease, 170 Primary Nongynecologic Malignancy, 170 Pelvic Kidney, 170 Gynecologic, 170 Tuboovarian Abscess, 170 Ectopic Pregnancy, 170 Leiomyoma, 170 Fallopian Tube Neoplasia, 170 Ovarian Neoplasm, 170 Differential Diagnoses of Ovarian Mass, 170 Germ Cell Tumors, 170 Sex Chord Stromal Tumors, 174 Epithelial Ovarian Neoplasia, 176 Metastatic Malignancy, 183 Other, 183 Evaluation and Management of the Pelvic Adnexal Mass, 184 Preoperative Evaluation, 184 Operative Management, 185 Ovarian Cancer Screening, 186 Pelvic Examination, 187 Transabdominal Ultrasonography, 187 Trans vaginal Ultrasonography, 187 Serum CA 125, 188 Multimodality Screening, 188 Recommendations for Screening, 188 10 The Breast, 191 Anatomy and Development, 191 Surgical Anatomy of the Breast, 191 Risk Factors for Breast Cancer, 192 Age, 193 Genetics and Family History, 193 Histopathologic Factors, 193 Dietary and Environmental Factors, 194 Hormonal and Reproductive Factors, 194 Oral Contraceptives and Breast Cancer, 194 Postmenopausal Hormone Replacement Therapy and Breast Cancer Risk, 194 Summary, 195 Work Up of the Patient with a Breast Problem, 195 Pertinent History, 195 Physical Examination, 196 Imaging Studies, 197 Mammography, 197 Ultrasonography, 197 Management of Specific Breast Problems, 197 Discrete Palpable Masses, 197 Cysts, 197 Solid Masses, 198 Vague Thickening or Nodularity, 198 BreastPain, 199 Nipple Discharge and Other Nipple and Areola Abnormalities, 199 Nipple Discharge, 199 Other Nipple and Areola Abnormalities, 199 Breast Infections, 200 Breast Abnormalities in Pregnant or Lactating Women, 200 Nonpalpable Mammographic Abnormalities, 201 Management of Patients at High Risk, 201 The Persistently Worried Patient with a Negative Work Up, 202 Biopsy Techniques, 202 Fine Needle Aspiration, 202 Core Needle Biopsy, 202 Open Biopsy, 202 Choice of Biopsy Technique, 202 Analysis of Tissue Obtained at Biopsy, 203 Hormone Receptor Levels, 203 DNA Ploidy and S Phase Fraction, 203 Molecular Markers and Other Prognostic Factors, 203 Breast Cancer Screening, 203 Theory and Current Modalities, 203 Current Issues in Breast Cancer Screening, 204 Screening Issues in Women 40 to 49 Years of Age, 204 Recommendations for Current Screening Practice, 204 Carcinoma of the Breast, 205 Staging of Breast Cancer, 205 Evolution of Treatment of Breast Cancer, 205 Radiation Therapy for Breast Cancer, 207 Eligibility for Lumpectomy and Radiation, 207 Contraindications to Breast Conservation, 208 Contraindications to Radiation Therapy, 208 Technical and Cosmetic Issues Related to Lumpectomy, 208 Local Recurrence, 208 Breast Reconstruction After Mastectomy, 208 Systemic Therapy for Breast Cancer: Chemotherapy and Hormone Therapy, 209 Carcinoma in Situ, 209 Ductal Carcinoma in Situ, 209 Current Treatment of DCIS, 209 Lobular Carcinoma in Situ, 210 Treatment for Early Invasive Breast Cancer, 210 Local Treatment, 210 Adjuvant Therapy, 210 Treatment for Advanced Breast Cancer, 211 Pregnancy and Hormone Replacement After Breast Cancer, 211 Pregnancy After Breast Cancer, 211 Hormone Replacement Therapy After Breast Cancer, 211 Detailed Contents xix Future Directions in the Treatment of Breast Cancer, 212 Surgery and Radiation, 212 Systemic Therapy, 212 Chemoprevention of Breast Cancer, 212 Silicone Breast Implants, 213 11 Gestational Trophoblastic Disease, 218 Management of Molar Pregnancy and Gestational Trophoblastic Tumors, 218 Epidemiology, 218 Molar Pregnancy, 219 Complete versus Partial Molar Pregnancy, 219 Pathologie and Chromosomal Features, 219 Complete Molar Pregnancy, 219 Signs and Symptoms, 219 Partial Molar Pregnancy, 220 Signs and Symptoms, 220 Ultrasonography and Diagnosis of Hydatidiform Mole, 220 Natural History of Molar Pregnancy and Prognostic Factors, 220 Surgical Evacuation, 221 Role of Prophylactic Chemotherapy, 221 Hormonal Follow up, 221 Gestational Trophoblastic Tumors, 222 Pathology Considerations, 222 Natural History, 222 Nonmetastatic Disease, 222 Metastatic Disease, 222 Staging System, 222 Diagnostic Evaluation, 222 Management of Stage I Gestational Trophoblastic Tumor, 223 Management of Stages II and III Gestational Trophoblastic Tumor, 224 Management of Stage IV Gestational Trophoblastic Tumor, 226 Follow up, 226 Chemotherapy, 227 Single Agent Chemotherapy, 227 Selection of Single Agent Chemotherapy, 227 Combination Chemotherapy, 227 Subsequent Pregnancies, 227 Pregnancy After Hydatidiform Mole, 227 Pregnancy After Gestational Trophoblastic Tumor, 228 Part III THE REPRODUCTIVE LIFE CYCLE, 231 12 Pediatric and Adoloescent Gynecology, 233 Office Evaluation of the Child and Adolescent, 234 Office Evaluation of the Child, 234 Obtaining the History, 234 Gynecologic Examination, 234 XX Detailed Contents Office Evaluation of the Adolescent, 237 Obtaining the History, 238 Gynecologic Examination, 238 Gynecologic Problems in the Pediatric Population, 240 Congenital Malformations, 240 Normal Female Embryology, 240 Ambiguous Genitalia in the Newborn, 241 Introital Abnormalities, 244 Masses, 244 Perineal Fissure, 245 Labia Minora Hypertrophy or Asymmetry, 245 Clitoromegaly, 245 Inguinal Ovary Syndrome, 245 Cloacal Anomalies, 245 Infection, 246 Vulvovaginitis, 246 The Normal Vaginal Environment, 246 Physiologie Leukorrhea, 247 Nonspecific Vulvovaginitis, 247 Specific Vulvovaginitis, 247 Gonorrhea, 247 Candida Albicans, 249 Trichomonas, 249 Pinworms, 249 Condylomata Acuminata, 249 Molluscum Contagiosum, 249 Systemic Causes, 249 Anatomie Causes, 250 Foreign Bodies, 250 Labial Adhesions, 250 Vaginal Bleeding, 251 Vulvovaginitis, 251 Coagulation Disorder, 251 Prolapse of the Urethra, 251 Premature Menarche, 252 Liehen Sclerosis, 252 Clitoral Infection, 252 Genital Trauma, 253 Trauma to the External Genitalia, 253 Sexual Abuse: The Gynecologist s Role, 253 Colposcopic Evaluation of the Hymen, 254 Gynecologic Findings During the Examination, 255 Repair of Sexual Trauma, 255 Tumors, 255 Labial Masses, 255 Abdominal/Pelvic Masses, 255 Benign Ovarian Cysts, 255 Malignant Tumors, 256 Vaginal Masses in the Pediatric Population, 256 Benign, 256 Malignant, 256 Ovarian Transposition for Radiation Therapy, 256 Gynecologic Problems at Puberty, 256 Normal Pubertal Development, 256 Abnormal Pubertal Development, 257 Premature Thelarche, 257 Premature Adrenarche, 258 Precocious Puberty, 258 Gynecologic Problems of the Adolescent Population, 259 Infections, 259 Pelvic Inflammatory Disease, 259 Sexual Assault, 260 Menstrual Disorders, 262 Delayed Menarche, 262 Primary Amenorrhea, 263 Secondary Amenorrhea, 263 Abnormal Bleeding, 263 Chronic Anovulation, 265 Control of Abnormal Bleeding for Patients Receiving Chemotherapy, 266 Dysmenorrhea, 266 Pelvic Pain, 267 Acute Pelvic Pain, 267 Chronic Pelvic Pain, 268 Treatment of Endometriosis in Adolescents, 271 Obstructing and Nonobstructing Malformations of the Reproductive Tract, 271 Classification of Uterovaginal Anomalies, 272 Imperforate Hymen with Hematocolpos (or Hydrocolpos), 272 Uterine Duplication with Obstructed Hemivagina, 273 Blind Uterine Hörn, 273 Transverse Vaginal Septum, 273 Cervicovaginal Agenesis, 274 Nonobstructive Malformations, 274 Longitudinal Vaginal Septa, 274 Uterine Agenesis, 274 Vaginal Agenesis, 274 Hymenal Anomalies, 275 Vulvar Anomalies, 275 Gynecologic Sequelae of Bladder Exstrophy, 276 Cloacal Anomalies, 277 Gynecologic Problems in Chronic Diseases, 277 Cystic Fibrosis, 277 Chronic Renal Disease, 278 Diabetes Mellitus, 278 Crohn Disease, 278 Sickle Cell Disease, 279 Childhood Malignancy, 279 Adnexal Masses, 279 Uterine Myomas, 281 BreastMass, 281 13 Conception Control, 285 Oral Contraceptives, 286 Administration and Types of Oral Contraceptives, 286 Mechanisms of Action, 286 Advantages, 288 Disadvantages, Side Effects, and Contraindications, 289 Barrier Methods and Spermicides, 293 Condoms (Prophylactics), 293 Spermicidal Agents, 294 Intravaginal Devices, 294 Intrauterine Devices, 295 Mechanism of Action, 295 Insertion Technique, 296 Disadvantages, Adverse Effects, and Contraindications, 296 Postcoital Contraception and Treatment for Sexual Assault, 297 Therapy for Sexual Assault, 299 Long Acting Progestins and Other Agents, 300 Subdermal Levonorgestrel Implant (Norplant), 301 Mechanism of Action, 302 Side Effects, 302 Insertion and Removal Techniques, 302 Reversible Methods with High Failure Rates, 304 Sterilization, 305 Laparoscopic Tubal Sterilization, 306 Minilaparotomy, 307 Pregnancy Termination, 308 Pharmacotherapeutic Methods, 308 Agents Disrupting Chorionic Villi, 308 Uterotonic Agents, 310 Agents for Softening the Cervix, 312 Conventional Methods of Induced Abortion, 313 Multifetal Pregnancy Reduction, 319 14 The Infertile Couple, 325 Epidemiology and Fecundability, 326 Causes of Infertility, 327 The Initial Visit, 327 The Ovarian Factor, 329 Premature Ovarian Failure, 329 Diminished Ovarian Reserve, 329 Hyperprolactinemia, 330 Hypothalamic Amenorrhea, 330 Luteal Phase Defect, 330 Thyroid Disease, 331 Adrenal Disease, 331 Techniques for Predicting and Detecting Ovulation, 332 Basal Body Temperature Chart, 332 Midluteal Serum Progesterone, 332 Endometrial Biopsy, 332 Ultrasound Monitoring, 332 Luteinizing Hormone Monitoring, 333 Treatment of Ovulatory Dysfunction, 333 Clomiphene Citrate, 334 Gonadotropin Therapy, 336 Bromocriptine, 338 Pulsatile GnRH, 339 Detailed Contents xxi Fertility Medications and the Risks for Ovarian Cancer, 339 Surgical Treatment of Anovulation, 340 Tubal and Peritoneal Factor Infertility, 340 Hysterosalpingography, 340 Laparoscopy, 341 Salpingoscopy, 343 Future Diagnostic Procedures, 343 Treatment of Tubal and Peritoneal Factor Infertility, 343 ¦ Tubal Reconstruction, 343 Assisted Reproduction and In Vitro Fertilization, 344 Patient Selection and Indications for In Vitro Fertilization, 344 Ovarian Stimulation, 344 Oocyte Retrieval and Fertilization, 345 Embryo Culture and Transfer, 345 Luteal Phase Support, 347 Gamete Intrafallopian Transfer, 347 Intracytoplasmic Sperm Injection, 348 Cryoembryo Transfer, 348 In Vitro Fertilization with Donor Oocytes, 349 Pregnancy Outcome, 349 Risks with In Vitro Fertilization Embryo Transfer, 350 New Frontiers in Assisted Reproduction, 350 Treatment of Endometriosis Associated Infertility, 351 Treatment of Advanced Stage Endometriosis, 351 Treatment of Early Stage Endometriosis, 353 The Male Factor, 354 Diagnostic Tests for the Evaluation of the Male, 354 Semen Analysis, 354 Testing Sperm Function, 356 Varicocele, 357 Gonadal Failure, 357 Isolated Gonadotropin Deficiency, 357 Obstructive Abnormalities of the Vas Deferens or Epididymis, 358 Retrograde Ejaculation, 358 Spinal Cord Injury, 358 Idiopathic Oligoasthenospermia, 358 Intrauterine Inseminations, 359 Therapeutic Donor Insemination, 359 In Vitro Fertilization and Intracytoplasmic Sperm Injection, 359 The Cervical Factor and Immunologie Infertility, 359 The Postcoital Test, 359 Treatment of Cervical Factor and Immunologie Infertility, 361 Intrauterine Insemination, 361 Treatment of Antisperm Antibodies, 362 Uterine Factors, 362 Unexplained Infertility, 363 Summary, 364 xxii Detailed Contents 15 Polycystic Ovary Syndrome and Hyperandrogenism, 373 Pathophysiology of Hyperandrogenism, 373 Clinical Features of Hyperandrogenism, 375 Hirsutism, 375 Alopecia, 376 Acne, 376 Menstrual Irregularity and Infertility, 376 Virilization, 376 Behavior, 376 Differential Diagnosis and Pathophysiology, 377 Idiopathic Hirsutism, 377 Polycystic Ovary Syndrome and Ovarian Hyperthecosis, 377 Androgen Secreting Ovarian Tumors, 382 Postmenopause, 382 Adrenal Masculinizing Conditions, 382 Hyperprolactinemia, 384 Hypothyroidism, 384 Disorders of Sexual Differentiation, 384 Anorexia Nervosa and Starvation, 384 Insulin Resistance, 384 Obesity, 384 Iatrogenic or Factitious Masculinization, 385 Diagnostic Strategy, 385 Whom to Evaluate, 385 Medical History, 385 Physical Examination, 385 Initial Laboratory Studies, 386 Additional Diagnostic Studies, 387 Dynamic Hormonal Testing, 387 Imaging Studies, 387 Invasive Procedures, 387 Therapeutic Options, 388 Goals ofTherapy, 388 Nonpharmacologic, 388 Endometrial Protection, 388 Oral Contraceptive Pills, 389 Glucocorticoids, 390 Antiandrogens, 390 Spironolactone, 390 Cyproterone Acetate, 391 Flutamide, 391 OtherAgents, 391 5a Reductase Inhibitors, 391 Ketoconazole, 391 Long Acting Gonadotropin Releasing Hormone Analogues, 391 Cimetidine, 392 Insulin Lowering Agents, 392 Ovarian Surgery, 392 Bromocriptine, 392 Thyroid Hormone Therapy, 392 Summary, 392 16 Recurrent Pregnancy Loss, 396 Possible Etiologies, 396 Genetic Factors, 396 Anatomie Factors, 398 Endocrine Factors, 399 Infectious Factors, 399 Immunologie Factors, 400 Autoimmune, 400 Alloimmune, 401 Miscellaneous Factors, 402 Environmental, 402 Placental Anomalies, 403 Maternal Illness, 403 Male Factors, 404 Asynchronous Fertilization, 404 Coitus, 404 Exercise, 404 Evaluation, 404 Preconception Assessment, 405 Physical Examination, 405 Laboratory Testing, 405 Genetic Assessment, 405 Anatomie Assessment, 406 Endocrinologic Assessment, 406 Infection Assessment, 407 Immunologie Assessment, 407 Postconception Monitoring, 409 Therapy, 411 Chromosomal Factors, 412 Anatomie Factors, 412 Endocrine Factors, 412 Infections, 413 Immunologie Factors, 413 Antiphospholipid Syndrome, 413 Alloimmune Recurrent Pregnancy Loss, 414 Other Therapeutic Considerations, 415 Prognosis, 416 Conclusion, 416 17 Medical Genetics, 423 General Principles, 424 Cytogenetic Inheritance, 424 Karyotype Analysis, 424 Abnormalities of Chromosome Inheritance, 427 Abnormalities of Chromosome Number, 428 Abnormalities of Chromosome Structure, 429 Mendelian Inheritance, 431 Diagnostic Technologies, 431 Patterns of Inheritance, 433 Multifactorial or Polygenic Inheritance, 434 Nonmendelian Inheritance, 435 Mitochondrial, 435 Unstable DNA, 436 Uniparental Disomy, 436 Imprinting, 437 Genetics in Gynecologic Practice, 437 Disorders of Sexual Differentiation, 437 Embryology, 437 Clinical Disorders of Sexual Differentiation, 438 Aneuploidies of Sex Chromosomes, 443 Reproductive Loss, 443 Spontaneous Miscarriage, 443 Recurrent Spontaneous Abortion, 445 Infertility, 445 Common Gynecologic Variants and Disorders, 445 Physiological Variants, 445 Müllerian Abnormalities, 446 Endometriosis, 446 Polycystic Ovarian Syndrome, 446 Premature Ovarian Failure, 446 Gynecologic Cancers, 446 Ovarian Carcinoma, 447 Gestational Trophoblast Disease, 448 Genetic Screening in Gynecologic Practice, 448 Genetic Diseases of Adult Onset, 448 Preconception Counselling, 448 Population Specific Genetic Screening, 449 Risk for Chromosome Disorders, 449 Risk for Multifactorial Diseases, 450 Women at Risk for Teratogen Exposure, 451 Maternal Diseases, 451 Recreational Exposures, 453 18 Gynecologic Infections, 455 Prevention of Gynecologic Infections, 455 Pelvic Inflammatory Disease, 456 Diagnosis, 457 Treatment, 460 Follow up and Prevention, 461 Rare Etiologic Agents for Pelvic Inflammatory Disease, 461 Actinomycosis, 461 Genital Tract Tuberculosis, 462 Gonorrhea, 462 Diagnosis, 463 Treatment, 464 Follow up and Prevention, 465 Chlamydia, 465 Diagnosis, 465 Treatment, 466 Follow up and Prevention, 466 Genital Herpes, 466 Diagnosis, 468 Treatment, 469 Follow up and Prevention, 470 Syphilis, 470 Diagnosis, 471 Treatment, 471 Follow up and Prevention, 472 Detailed Contents xxiii Chanchroid, 472 Diagnosis, 472 Treatment, 472 Follow up and Prevention, 473 Lymphogranuloma Venereum, 473 Diagnosis, 473 Treatment, 473 Follow up and Prevention, 474 Donovanosis, 474 Diagnosis, 474 Treatment, 474 Follow up and Prevention, 474 Genital Warts, 474 Diagnosis, 475 Treatment, 475 Follow up and Prevention, 476 Molluscum Contagiosum, 476 Diagnosis, 476 Treatment, 476 Vaginitis, 476 Candidiasis, 477 Trichomoniasis, 478 Bacterial Vaginosis, 479 Other Causes of Vaginitis Symptoms, 480 Urinary Tract Infection, 480 Diagnosis, 481 Treatment, 482 Follow up and Prevention, 482 Human Immunodeficiency Virus Infection, Including Acquired Immunodeficiency Syndrome, 482 19 Endometriosis, 492 Etiology, 492 Epidemiology, 494 Pathology, 495 Clinical Features, 497 Symptoms, 497 Signs, 497 Diagnosis and Staging, 498 Clinical Presentation, 500 PelvicPain, 500 Infertility, 501 Pelvic Mass, 502 Treatment, 502 PelvicPain, 502 Prophylaxis, 502 Observation and Analgesia, 503 Hormonal Therapy, 503 Surgical Treatment, 512 Infertility, 513 Pelvic Mass, 515 20 Psychological Aspects of Women s Reproductive Health, 519 Premenstrual Dysphoric Disorder, 520 Postpartum Depression, 524 xxiv Detailed Contents Infertility, 529 Menopause, 533 Summary, 535 21 Menopause, 540 Aging of the Ovary, 540 Vasomotor Flushes, 542 Definitions and Pathophysiology, 542 Etiology, 542 Diagnosis, 544 Treatment, 544 Estrogens, 544 Progestins, 545 a Adrenergic Agonists, 545 Veralipride, 545 Bellergal, 545 Herbs, 545 Osteoporosis, 545 Definition and Etiology, 545 Incidence, 546 Diagnosis, 547 Treatment, 547 Estrogens, 547 Progestins, 548 Raloxifene, 548 Bisphosphonates, 548 Calcitonin, 549 Calcium, 549 Vitamin D, 549 Fluoride, 550 Thiazide Diuretics, 550 Genital Atrophy, 550 Pathogenesis, 550 Diagnosis, 551 Treatment, 551 Atherosclerosis, 551 Epidemiological Studies, 552 Angiographic Studies, 552 Clinical Trials, 553 Mechanisms of Action of Estrogen, 553 Cognition, 555 SkinEffects, 555 Estrogens, 556 Pharmacology, 556 Possible Side Effects, 557 Endometrial Neoplasia, 557 Ovarian Neoplasia, 558 Breast Neoplasia, 558 Gallbladder Disease, 559 Thromboembolic Disease, 559 Hypertension, 559 Glucose Tolerance, 559 Contraindications, 559 Progestogens, 560 Available Preparations, 560 Adverse Effects, 560 Hormone Treatment Regimens, 560 Raloxifene, 561 Effects on Bone, 561 Effects on Cardiovascular Risk Markers, 562 Effects on Venous Thromboembolic Disease, 564 Effects on the Uterus, 564 Effects on the Breast, 564 Effect on Central Nervous System, 565 Tamoxifen, 565 Clinical Studies, 565 Conclusions, 565 22 Urogynecology and Pelvic Floor Dysfunction, 570 Epidemiology, 570 Urinary Incontinence, 570 Prevalence, 570 Psychosocial, 570 Costs, 571 Pelvic Floor Prolapse, 571 Anal Incontinence, 571 Embryology of the Lower Urinary Tract, 571 Kidneys and Ureters, 571 Bladder and Urethra, 572 Histology, 573 Urinary Tract Anatomy, 574 Ureters, 574 Bladder, 574 Urethra, 575 Pelvic Floor Functional Anatomy, 576 Bony Pelvis, 576 Pelvic Floor Muscles, 576 Endopelvic Fascia, 577 Malformations, 578 Physiology, 578 Pharmacology of the Lower Urinary Tract, 580 Urinary Incontinence: Urinary Storage and Evacuation Anomalies, 580 Classification and Evaluation, 580 Classification, 580 Clinical Evaluation of the Lower Urinary Tract, 580 Basic Urodynamic Investigations, 584 Special Urodynamic Investigations, 585 Imaging Studies, 587 Genuine Stress Incontinence, 587 Cause, 587 Diagnosis, 588 Treatment, 588 Detrusor Instability and Hyperreflexia, 591 Cause, 591 Diagnosis, 591 Treatment, 591 Mixed Incontinence, 593 Genuine Stress Incontinence and Detrusor Instability, 593 Genuine Stress Incontinence and Voiding Dysfunction, 593 Detrusor Instability and Voiding Dysfunction, 593 Overflow Incontinence and Voiding Dysfunction, 593 Cause, 593 Diagnosis, 593 Treatment, 593 Genitourinary Fistula, 594 Urethral Diverticulum, 595 Cause, 595 Diagnosis, 595 Treatment, 595 Painful Bladder Syndrome, 595 Urethral Syndrome, 595 Interstitial Cystitis, 596 Sensory Urgency, 596 Urinary Tract Infections, 596 Cause, 597 Diagnosis, 597 Treatment, 597 Menopause and the Lower Urinary Tract, 598 Disorders of Pelvic Floor Support, 599 Pathophysiology, 599 Clinical Presentation, 599 Physical Examination, 599 Imaging Studies, 600 Fluoroscopy, 600 Magnetic Resonance Imaging, 601 Ultrasonography, 601 Management, 601 Behavioral, 601 Mechanical, 602 Surgical, 602 Anal Incontinence, 604 Anatomy, 604 Causes, 604 Diagnosis, 604 Prevention, 604 Management, 604 23 Geriatrie Gynecology and Aging, 610 Geriatrics Overview, 610 Demographics and Epidemiology, 610 Biology of Aging, 610 Relevant Anatomie and Physiologie Changes, 610 Homeostenosis, 611 Principles of Geriatrie Medicine, 611 Impaired Reserve Leads to Earlier Development of Symptoms, 611 Disease Often Presents Through the Weakest Organ System, 611 Abnormal Findings in the Elderly May Not Equal Disease, 611 Etiologies are Multifactorial; Treatments Should Be Multifaceted, 611 Detailed Contents xxv Small Improvements in Diverse Areas May Yield Large Results, 612 Treatment and Prevention Are Effective, 612 Pharmacology, 612 Changes in Volume of Distribution, 613 Changes in Clearance: Hepatic and Renal, 613 Evaluation of the Elderly Woman, 613 Functional Assessment, 613 Communication with the Elderly, 613 History, 615 Pelvic Examination, 615 Hormone Replacement Therapy in the Elderly, 616 Differences in the Elderly, 617 Cardiovascular Disease, 617 Cerebrovascular Disease, 617 Osteoporosis, 617 Vision, 617 Colon Cancer, 618 Alzheimer s Disease, 618 Osteoarthritis, 618 Urinary Incontinence and Infections, 618 Menopausal Symptomatology, 618 Breast Cancer, 618 Initiation, 618 Doses, Side Effects, and Difficulties, 618 Androgens, 620 Selective Estrogen Receptor Modulators, 620 Age Related Aspects of Gynecologic Conditions, 620 Osteoporosis, 620 Definition, 620 Pathophysiological Differences in the Elderly, 620 Evaluation, 621 Treatment, 621 Lower Urinary Tract Dysfunction, 621 Lower Urinary Tract Changes with Aging, 621 Causes of Transient Incontinence, 622 Causes of Established Incontinence, 622 Diagnostic Approach, 624 History, 624 Physical Examination, 624 Voiding Record, Stress Testing, Postvoid Residual Volume Measurement, 624 Empirie Diagnostic Categorization. 624 Therapy, 624 Detrusor Overactivity, 624 Stress Incontinence, 625 Underactive Detrusor, 626 Urinary Tract Infection, 626 Asymptomatic Bacteriuria. 626 Symptomatic Urinary Tract Infection, 626 Pelvic Organ Prolapse, 627 Sexuality, 627 Changes with Aging, 627 Evaluation, 628 Conditions and Treatments, 628 Vulvovaginal Disorders, 629 xxvi Detailed Contents Perioperative Care, 629 Perioperative Evaluation, 630 Risk Assessment, 630 Cardiac Function, 630 Pulmonary Function, 630 Renal and Gastrointestinal Function, 631 Cognitive Function, 631 Other Medical Conditions, 631 Operative Care, 631 Postoperative Measurement, 632 BedRest, 632 Delirium, 632 Pain Management, 632 Infections, 632 Discharge Planning, 632 Cancer Screening, 633 Cancer Mortality, 633 Age Limits of Screening, 633 Health Status, 633 QualityofLife, 633 Breast Cancer Screening (Mammography), 634 Colorectal Cancer Screening, 634 Cervical Cancer Screening, 634
any_adam_object	1
building	Verbundindex
bvnumber	BV012855857
callnumber-first	R - Medicine
callnumber-label	RG101
callnumber-raw	RG101
callnumber-search	RG101
callnumber-sort	RG 3101
callnumber-subject	RG - Gynecology and Obstetrics
classification_rvk	YM 1300
ctrlnum	(OCoLC)40964902 (DE-599)BVBBV012855857
dewey-full	618.1
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	618 - Gynecology, obstetrics, pediatrics, geriatrics
dewey-raw	618.1
dewey-search	618.1
dewey-sort	3618.1
dewey-tens	610 - Medicine and health
discipline	Medizin
edition	7. ed.
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01528nam a2200445 c 4500</leader><controlfield tag="001">BV012855857</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19991228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">991112s1999 ad\|\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0323002013</subfield><subfield code="9">0-323-00201-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)40964902</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012855857</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RG101</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">618.1</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YM 1300</subfield><subfield code="0">(DE-625)153814:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Kistner's gynecology and women's health</subfield><subfield code="c">Kenneth J. Ryan ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Gynecology and woman's health</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">7. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">St. Louis [u.a.]</subfield><subfield code="b">Mosby</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVI, 660 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Frau</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genital Diseases, Female</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genital Neoplasms, Female</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Women</subfield><subfield code="x">Health and hygiene</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Women's Health</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gynäkologie</subfield><subfield code="0">(DE-588)4018225-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4123623-3</subfield><subfield code="a">Lehrbuch</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gynäkologie</subfield><subfield code="0">(DE-588)4018225-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ryan, Kenneth J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008747421&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008747421</subfield></datafield></record></collection>
genre	(DE-588)4123623-3 Lehrbuch gnd-content
genre_facet	Lehrbuch
id	DE-604.BV012855857
illustrated	Illustrated
indexdate	2024-07-09T18:34:53Z
institution	BVB
isbn	0323002013
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-008747421
oclc_num	40964902
open_access_boolean
owner	DE-355 DE-BY-UBR
owner_facet	DE-355 DE-BY-UBR
physical	XXVI, 660 S. Ill., graph. Darst.
publishDate	1999
publishDateSearch	1999
publishDateSort	1999
publisher	Mosby
record_format	marc
spelling	Kistner's gynecology and women's health Kenneth J. Ryan ... Gynecology and woman's health 7. ed. St. Louis [u.a.] Mosby 1999 XXVI, 660 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Frau Genital Diseases, Female Genital Neoplasms, Female Gynecology Women Health and hygiene Women's Health Gynäkologie (DE-588)4018225-3 gnd rswk-swf (DE-588)4123623-3 Lehrbuch gnd-content Gynäkologie (DE-588)4018225-3 s DE-604 Ryan, Kenneth J. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008747421&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	Kistner's gynecology and women's health Frau Genital Diseases, Female Genital Neoplasms, Female Gynecology Women Health and hygiene Women's Health Gynäkologie (DE-588)4018225-3 gnd
subject_GND	(DE-588)4018225-3 (DE-588)4123623-3
title	Kistner's gynecology and women's health
title_alt	Gynecology and woman's health
title_auth	Kistner's gynecology and women's health
title_exact_search	Kistner's gynecology and women's health
title_full	Kistner's gynecology and women's health Kenneth J. Ryan ...
title_fullStr	Kistner's gynecology and women's health Kenneth J. Ryan ...
title_full_unstemmed	Kistner's gynecology and women's health Kenneth J. Ryan ...
title_short	Kistner's gynecology and women's health
title_sort	kistner s gynecology and women s health
topic	Frau Genital Diseases, Female Genital Neoplasms, Female Gynecology Women Health and hygiene Women's Health Gynäkologie (DE-588)4018225-3 gnd
topic_facet	Frau Genital Diseases, Female Genital Neoplasms, Female Gynecology Women Health and hygiene Women's Health Gynäkologie Lehrbuch
url	http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008747421&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT ryankennethj kistnersgynecologyandwomenshealth AT ryankennethj gynecologyandwomanshealth

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge